Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 10894063
Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
granted -
US 10894966
Virus-based expression vectors and uses thereof
granted -
US 10894797
Fused tricyclic ring derivatives as SRC homology-2 phosphatase inhibitors
granted -
US 10894078
HIV vaccines comprising one or more population episensus antigens
granted -
US 10894073
Pinot noir grape products for nonalcoholic fatty liver disease and other uses
granted -
US 10894087
Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds
granted -
US 10894052
Heterocyclic inhibitors of ATR kinase
granted -
US 10894808
Polypeptide ligands specific for plasma kallikrein
granted -
US 10894863
Cathode materials for Li—S batteries
granted -
US 10894050
Methods of synthesizing thyroid hormone analogs and polymorphs thereof
granted -
US 10894053
Pharmaceutical compositions comprising meloxicam
granted -
US 10894065
Methods for production of platelets from pluripotent stem cells and compositions thereof
granted -
US 10894804
Nucleotide hemi-sulfate salt for the treatment of hepatitis C virus
granted -
WO 2021005493
ANTAGONISTES DU CGRP ET TOXINES BOTULINIQUES POUR LE TRAITEMENT DE TROUBLES INFLAMMATOIRES ET NEUROLOGIQUES
granted -
WO 2021005497
ANTAGONISTES DU CGRP ET DÉRIVÉS DE CLOSTRIDIUM POUR LE TRAITEMENT DE TROUBLES ASSOCIÉS À LA DÉPRESSION CORTICALE ENVAHISSANTE
granted -
WO 2021005494
ANTAGONISTES DU CGRP ET DÉRIVÉS DE CLOSTRIDIALES POUR LE TRAITEMENT DE TROUBLES NEUROPSYCHIATRIQUES ET NEUROLOGIQUES
granted -
US 10889576
Phthalazinone compounds and methods for the treatment of cystic fibrosis
granted -
US 10888554
Salts of heterocyclic modulators of HIF activity for treatment of disease
granted -
US 10888578
Exon skipping oligomer conjugates for muscular dystrophy
granted -
US 10888581
Chimeric antigen receptor and methods of use thereof
granted -
US 10889577
Solid forms of an sGC stimulator
granted -
US 10888609
CD200 inhibitors and methods of use thereof
granted -
US 10889637
Methods of treating an osteolytic tumor and spinal cord injury by administering connexin (Cx) 43 hemichannel-binding antibodies
granted -
US 10888529
Vehicles for the transfection of miRNAs
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.